CLINICOPATHOLOGIC AND RADIOLOGIC CHARACTERISTICS OF LUNG CANCER PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), K-RAS MUTATION AND ANAPLASTIC LYMPHOMA KINASE (ALK) REARRANGEMENT PRESENTED AS NODULAR GROUND-GLASS OPACITY

被引：0
|
作者：
Lee, Jae Ho [1 ]
Ko, Sung-Jun [2 ]
Lee, Yeong Joo [1 ]
Park, Jong Sun [1 ]
Cho, Young-Jae [1 ]
Yoon, Ho-Il [1 ]
Chung, Jin-Haeng [3 ]
Jheon, Sanghoon [3 ]
Lee, Choon-Taek [1 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Seoul 151, South Korea
[2] Seoul Natl Univ Hosp, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Bundang Hosp, Seoul 151, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
EGFR; Lung cancer; K-ras; ALK;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S665 / S665
页数：1
相关论文
共 50 条
  • [41] Role of epidermal growth factor receptor overexpression, K-ras point mutation and c-myc amplification in the carcinogenesis of non-small cell lung cancer
    Sekine, I
    Takami, S
    Guang, SG
    Yokose, T
    Kodama, T
    Nishiwaki, Y
    Kinoshita, M
    Matsumoto, H
    Ogura, T
    Nagai, K
    ONCOLOGY REPORTS, 1998, 5 (02) : 351 - 354
  • [42] Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non-small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices
    Ess, S. M.
    Herrmann, C.
    Frick, H.
    Krapf, M.
    Cerny, T.
    Jochum, W.
    Frueh, M.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (06)
  • [43] Tumor response to radiotherapy and expression of epidermal growth factor receptor mutation and echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase rearrangement in patients with non-small cell lung cancer
    Nagi, Nadeem M. S.
    Khair, Yasir A. M.
    Bakari, Khamis H.
    Nagi, Mohamed N.
    Mghanga, Fabian P.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2022, 34 (01)
  • [44] Tumor response to radiotherapy and expression of epidermal growth factor receptor mutation and echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase rearrangement in patients with non-small cell lung cancer
    Nadeem M. S. Nagi
    Yasir A. M. Khair
    Khamis H. Bakari
    Mohamed N. Nagi
    Fabian P. Mghanga
    Journal of the Egyptian National Cancer Institute, 34
  • [45] Concomitant echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase rearrangement and epidermal growth factor receptor mutation in non-small cell lung cancer patients from eastern India
    Mohapatra, Prasanta Raghab
    Sahoo, Satyajeet
    Bhuniya, Sourin
    Panigrahi, Manoj Kumar
    Majumdar, Saroj Kumar Das
    Mishra, Pritinanda
    Patra, Susama
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (04) : 850 - 854
  • [46] Study of molecular changes in epidermal growth factor receptor (EGFR) and K-ras in non-small cell lung cancer (NSCLC) biopsies at time of progression compared to initial biopsy
    Speranza, Giovanna
    Cohen, Victor
    Agulnik, Jason S.
    Chong, George
    Meilleur, Francine
    Brandao, Guilherme
    Kasymjanova, Goulnar
    Small, David
    Miller, Jr Wilson H.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S928 - S929
  • [47] Clinical characteristics of patients with non-small cell lung cancers harboring anaplastic lymphoma kinase rearrangements and primary lung adenocarcinoma harboring epidermal growth factor receptor mutations
    Xu, L.
    Lei, J.
    Wang, Q. Z.
    Li, J.
    Wu, L.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04): : 12973 - 12983
  • [48] First-generation epidermal growth factor receptor tyrosine kinase inhibitors in EGFR mutation - Positive non-small cell lung cancer patients
    Sequist, Lecia V.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : S143 - S145
  • [49] Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients
    Chen, Kaiyan
    Yu, Xiaoqing
    Wang, Haiyang
    Huang, Zhiyu
    Xu, Yanjun
    Gong, Lei
    Fan, Yun
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (06) : 1179 - 1187
  • [50] Original Article Clinical effect of Almonertinib in treating epidermal growth factor receptor mutation-positive residual ground-glass opacities after stage I lung cancer resection
    Zhang, Jing
    Zhang, Zhao
    Zhou, Ying
    Huang, Chongbiao
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (12): : 7553 - 7562
12345